Baclofen-induced psychosis

Primary Psychiatry

Volumn 13, Issue 12, 2006, Pages 29-30

  Ginsberg, David L ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ANTIBIOTIC AGENT; BACLOFEN; CENTRAL MUSCLE RELAXANT; NONSTEROID ANTIINFLAMMATORY AGENT; OLANZAPINE;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG MECHANISM; DRUG WITHDRAWAL; HUMAN; JAW MUSCLE; LEG CRAMP; MALE; MENTAL DISEASE; MUSCLE SPASM; NECK MUSCLE; PSYCHOSIS; REVIEW; TETANUS;

EID: 33845674116     PISSN: 10826319     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. Standaert DG, Young AB. Treatment of central nervous system degenerative disorders. In: Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. Columbus, OH: McGraw-Hill; 2005:543.
2. Chawla JM, Sagar R. Baclofen-induced psychosis. Ann Pharmacother. 2006;40(11):2071-2073.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239-245.
4. Sommer BR, Petrides G. A case of baclofen-induced psychotic depression. J Clin Psychiatry. 1992;53(6):211-212.
5. Wolf ME, Almy G, Toll M, Mosnaim AD. Mania associated with the use of baclofen. Biol Psychiatry. 1982;17(6):757-759.
6. Yassa RY, Iskandar HL. Baclofen-induced psychosis: two cases and a review. J Clin Psychiatry. 1988;49(8):318-320.
7. Leo RJ, Baer D. Delirium associated with baclofen withdrawal: a review of common presentations and management strategies. Psychosomatics. 2005;46(6):503-507.
8. Chodorowski Z, Sein AJ, Wisniewski M. Acute intoxication with baclofen [Polish]. Przegl Lek. 2004;61:389-391.
9. Xi ZX, Stein E. Baclofen inhibits heroin self-administration behavior and mesolimbic dopamine release. J Pharmacol Exp Ther. 1999;290(3):1369-1374.
10. Leite-Morris KA, Fukudome EY, Shoeb M, Kaplan GB. GABA(B) receptor activation in the ventral tegmental area blocks opiate-induced motor stimulation and sensitization. J Pharmacol Exp Ther. 2004;308(2):667-678.
11. Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Res. 2003;987(1):122-125.
12. Gulmann NC, Bahr B, Andersen B, Eliassen HM. A double-blind trial of baclofen against placebo in the treatment of schizophrenia. Acta Psychiatr Scand. 1976;54(4):287-293.
13. Schopf J, Hucker H. Baclofen in the treatment of schizophrenia: a pilot study. Pharmakopsychiatr Neuropsychopharmakol. 1977;10(2):89-91.